Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLDR
2151
DELISTED
Cloudera, Inc.
CLDR
| $1.9M | ﹤0.01% |
149,419
-904,831
| -86% | -$8.69M |
|
2152
PUT
Chemours
CC
$2.26B
| $1.9M | ﹤0.01% |
123,500
-2,500
| -2% | -$31.6K |
|
2153
CEMIG Preferred Shares
CIG
$5.89B
| $1.9M | ﹤0.01% |
1,813,685
| – | – |
|
2154
Insperity
NSP
$2B
| $1.9M | ﹤0.01% |
29,269
-192,776
| -87% | -$9.65M |
|
2155
PUT
Novartis
NVS
$297B
| $1.9M | ﹤0.01% |
21,700
-64,700
| -75% | -$5.58M |
|
2156
Central Garden & Pet Co Class A
CENTA
$2.4B
| $1.89M | ﹤0.01% |
69,949
+7,859
| +13% | +$197K |
|
2157
Installed Building Products
IBP
$6.24B
| $1.89M | ﹤0.01% |
27,480
-7,129
| -21% | -$395K |
|
2158
Littelfuse
LFUS
$11.6B
| $1.89M | ﹤0.01% |
11,056
+10,249
| +1,270% | +$1.56M |
|
2159
PUT
Stellantis
STLA
$21B
| $1.89M | ﹤0.01% |
184,100
-155,300
| -46% | -$1.34M |
|
2160
Suncor Energy
SU
$73B
| $1.89M | ﹤0.01% |
111,859
-838,688
| -88% | -$14.3M |
|
2161
TriNet
TNET
$3.12B
| $1.89M | ﹤0.01% |
30,944
+5,788
| +23% | +$289K |
|
2162
Advanced Drainage Systems
WMS
$10.7B
| $1.88M | ﹤0.01% |
38,145
+1,638
| +4% | +$67.3K |
|
2163
ITT
ITT
$18.9B
| $1.88M | ﹤0.01% |
31,956
-494,424
| -94% | -$26.2M |
|
|
CSR
2164
Centerspace
CSR
$931M
| $1.88M | ﹤0.01% |
26,622
+9,506
| +56% | +$608K |
|
|
PCH
2165
DELISTED
PotlatchDeltic
PCH
| $1.87M | ﹤0.01% |
49,232
+14,351
| +41% | +$485K |
|
2166
CALL
CarMax
KMX
$8.39B
| $1.87M | ﹤0.01% |
20,900
-10,000
| -32% | -$784K |
|
2167
Glacier Bancorp
GBCI
$6.31B
| $1.87M | ﹤0.01% |
53,028
-17,380
| -25% | -$645K |
|
|
CCXI
2168
DELISTED
ChemoCentryx, Inc.
CCXI
| $1.87M | ﹤0.01% |
32,475
+18,874
| +139% | +$1.03M |
|
|
GAP
2169
CALL
The Gap Inc
GAP
$7.64B
| $1.87M | ﹤0.01% |
147,900
+48,600
| +49% | +$438K |
|
2170
CALL
Clorox
CLX
$12.9B
| $1.86M | ﹤0.01% |
8,500
-35,000
| -80% | -$6.99M |
|
2171
PUT
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.7B
| $1.86M | ﹤0.01% |
31,800
-105,100
| -77% | -$6.13M |
|
2172
National Vision
EYE
$1.78B
| $1.86M | ﹤0.01% |
61,113
+11,979
| +24% | +$314K |
|
2173
Euronet Worldwide
EEFT
$2.64B
| $1.86M | ﹤0.01% |
19,425
+3,235
| +20% | +$299K |
|
2174
Manhattan Associates
MANH
$11.5B
| $1.86M | ﹤0.01% |
19,739
-24,139
| -55% | -$1.8M |
|
|
SRG
2175
Seritage Growth Properties
SRG
$136M
| $1.86M | ﹤0.01% |
162,968
+90,601
| +125% | +$911K |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.